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Peptidoglycan recognition proteins (PGRPs) are
structurally conserved through evolution, but
their functions in innate immunity are different
in invertebrates and vertebrates. We asked
what the functions of PGRPs in fish are and
whether they are indispensable for defense
against infection because fish are the first verte-
brates that developed adaptive immunity, but
they still rely solely on innate immunity during
early development of embryos. We identified
and cloned three zebrafish PGRPs and showed
that they are highly expressed in eggs, develop-
ing embryos, and adult tissues that contact ex-
ternal environment. Zebrafish PGRPs have both
peptidoglycan-lytic amidase activity and broad-
spectrum bactericidal activity, which is a unique
feature. Furthermore, we demonstrated that in
the developing zebrafish embryo, one of these
PGRPs is essential for defense and survival dur-
ing bacterial infections. These data demonstrate
an absolute requirement for innate immunity in
defense against infections in fish embryos and
for a PGRP protein for survival in vertebrates.
INTRODUCTION
Innate immunity arose in the early multicellular organisms
and has remained an essential component of defense
mechanisms in all metazoans. Although all vertebrates de-
veloped acquired immunity, early vertebrates’ eggs and
embryos, which are laid and develop in water, must solely
rely on innate immunity in defense against infections until
their acquired immune system develops.
Peptidoglycan recognition proteins (PGRPs or
PGLYRPs) is a family of innate immunity molecules that
were first identified in insects (Yoshida et al., 1996; Kang
et al., 1998) and then in mammals (Kang et al., 1998; Liu
et al., 2001), other vertebrates, mollusks, and echino-518 Immunity 27, 518–529, September 2007 ª2007 Elsevier Inderms (Dziarski and Gupta, 2006b). The invertebrate and
vertebrate PGRP proteins are highly conserved in their
structure and recognize bacteria through their cell wall
component, peptidoglycan.
Peptidoglycan is a major component of bacterial cell
wall and is a polymer of b(1-4)-linkedN-acetylglucosamine
(GlcNAc) and N-acetylmuramic acid (MurNAc). MurNAc
has short peptides, typically containing four alternating L
and D amino acids. The third amino acid in Gram-negative
bacteria and Gram-positive bacilli is m-diaminopimelic
acid (DAP), and in most other Gram-positive bacteria (in-
cluding Gram-positive cocci), it is L-lysine (Lys) (Dziarski
and Gupta, 2006a; Dziarski and Gupta, 2006b).
Despite the structural similarities, invertebrate and ver-
tebrate PGRPs have acquired different functions. Insects
have many PGRPs that function in cell activation, phago-
cytosis, or hydrolysis of peptidoglycan (Werner et al.,
2000). The cell activating PGRPs stimulate either the Toll
(Drosophila PGRP-SA, PGRP-SD, and PGRP-SC1) (Mi-
chel et al., 2001; Bischoff et al., 2004; Garver et al.,
2006) or the Imd (Drosophila PGRP-LC) (Choe et al.,
2002; Gottar et al., 2002; Ramet et al., 2002) signal trans-
duction pathways, which induce transcription of antimi-
crobial peptides active against Gram-positive bacteria
and fungi (Lemaitre et al., 1996) or Gram-negative bacteria
(Lemaitre et al., 1995), respectively. The Toll and Imd path-
ways are preferentially triggered by either Lys-type or
DAP-type peptidoglycan, respectively (Leulier et al.,
2003; Kaneko and Silverman, 2005). Other PGRPs, such
as silkworm PGRP-S, activate the prophenol-oxidase
cascade, which also generates antimicrobial products
(Yoshida et al., 1996; Park et al., 2006). Finally, some
PGRPs, such as Drosophila PGRP-SC1, PGRP-LB, and
PGRP-SB1, are N-acetylmuramoyl-L-alanine amidases
(Kim et al., 2003; Mellroth et al., 2003; Mellroth and Steiner,
2006), which hydrolyze the lactyl-amide bond between
MurNAc and L-Ala. The function of these insect amidases
is to prevent excessive activation of the immune system
by bacteria (Mellroth et al., 2003; Zaidman-Remy et al.,
2006; Bischoff et al., 2006).
Mammals have a family of four PGRPs: PGLYRP-1,
PGLYRP-2, PGLYRP-3, and PGLYRP-4 (Liu et al., 2001;c.
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hypothesized to function as pattern-recognition receptors
similar to insect PGRPs (Liu et al., 2001). However, we
have demonstrated that human PGRPs have two major
functions: amidase and antibacterial activities. PGLYRP-
2, is an N-acetylmuramoyl-L-alanine amidase and is con-
stitutively expressed in the liver and secreted into the
bloodstream (Gelius et al., 2003; Wang et al., 2003; Zhang
et al., 2005). Its expression is also induced in keratinocytes
upon bacterial stimulation (Wang et al., 2005; Li et al.,
2006). PGLYRP-1 is present in the granules of polymor-
phonuclear leukocytes (Tydell et al., 2002; Dziarski et al.,
2003). PGLYRP-3 and PGLYRP-4 are expressed in tis-
sues that come in contact with the environment (Lu
et al., 2006). PGLYRP-1, PGLYRP-3, and PGLYRP-4 are
bactericidal and kill a wide range of Gram-positive and
Gram-negative bacteria (Lu et al., 2006; Wang et al.
2007). These PGLYRPs do not have amidase activity,
but their bactericidal activity relies on targeting bacterial
cell wall and does not involve peptidoglycan hydrolysis
or permeabilization of the cytoplasmic membrane (Lu
et al., 2006; Wang et al., 2007).
Insect PGRPs are not known to be bactericidal, except
for Drosophila PGRP-SB1, which has both N-acetylmura-
moyl-L-alanine amidase and bactericidal activities (Mell-
roth and Steiner, 2006). However, PGRP-SB1 is bacteri-
cidal for only one bacterial species, Bacillus megaterium,
which is likely due to its amidase activity (Mellroth and
Steiner, 2006). By contrast, mammalian PGLYRPs have
broad-spectrum bactericidal activity that does not rely
on amidase activity (Tydell et al., 2002; Lu et al., 2006;
Wang et al., 2007).
To gain insight into the evolution of the function of
PGLYRPs in innate immunity, we have identified a family
of PGLYRPs in an earlier vertebrate, the zebrafish, and we
studied their functions and role in defense against bacterial
infections. Zebrafish and other teleosts have a well-devel-
oped immune system that is similar to the mammalian im-
mune system and that, unlike invertebrates, includes both
innate and adaptive immunity (Yoder et al., 2002;Lam et al.,
2004; Trede et al., 2004). However, fish were the first verte-
brates to develop adaptive immunity, and it is not known
whether their innate immune systemhas greater similarities
to the invertebrate or to the higher vertebrate systems.
Zebrafish, thus, serves as an important model for the evo-
lutionary analysis of immune mechanisms and the role of
innate immunity in lower vertebrates (Trede et al., 2001;
Yoder et al., 2002; Lam et al., 2004; DeVries et al., 2006;
Trede et al., 2004). We show here that innate immunity
and PGLYRPs in particular are required for defense against
bacterial infections in developing fish embryos.
RESULTS
Cloning and Sequence Analysis
of Zebrafish PGLYRPs
In order to identify pglyrp genes in the zebrafish, we
searched GenBank databases for genes homologous to
human PGLYRPs. We identified four pglyrp genes in theImzebrafish genome (approximately 70% of the genome is
sequenced). We have cloned three of these genes and
have named them pglyrp-2, pglyrp-5, and pglyrp-6.
Zebrafish PGLYRP-2 was designated ‘‘2’’ because it had
the highest homology to mammalian PGLYRP-2 com-
pared to other zebrafish PGLYRPs. The other two zebra-
fish PGLYRPs were not considered orthologs of the re-
maining three mammalian PGLYRPs because unlike
these mammalian PGLYRPs, they are predicted ami-
dases, they are larger than PGLYRP-1, and they do not
have two PGRP domains, which are present in mamma-
lian PGLYRP-3 and PGLYRP-4. Thus, we named them
PGLYRP-5 and PGLYRP-6. We were unable to clone the
full-length cDNA for the fourth zebrafish PGLYRP that
was identified from an EST clone. The genome organiza-
tion (Figure S1 in the Supplemental Data available online)
and sequence analysis (Figure S2) of zebrafish PGLYRPs
is presented in the Supplemental Results.
Zebrafish PGLYRP proteins have no predicted signal
peptides. However, our immunohistochemistry data dem-
onstrate that all three proteins were present in the lumen of
blood vessels; this indicates that they are secreted. Ze-
brafish PGLYRPs were not glycosylated (data not shown),
unlike human PGLYRPs. Zebrafish PGLYRPs, similar to
most vertebrate and invertebrate PGRPs, all have one
C-terminal PGRP domain, which have 43%, 36%, and
42% conserved identities and 59%, 54%, and 57% con-
served similarities, respectively, with PGRP domains in
human PGLYRPs (Figure S2). All three zebrafish PGLYRPs
are predicted to have amidase activity because they all
have the conserved four Zn2+-binding amino acids, corre-
sponding to His411, Tyr447, His522, and Cys530 in human
PGLYRP-2, which is an amidase (Wang et al., 2003). These
four amino acids are conserved in all amidase-active
PGRPs and in bacteriophage and bacterial type-2 ami-
dases, such as bacteriophage T7 lysozyme. By contrast,
human PGLYRP-1, PGLYRP-3, and PGLYRP-4, which
are not amidases, do not have the last Cys conserved (cor-
responding to Cys530 in human PGLYRP-2).
Thus, we have identified four pglyrp genes in zebrafish,
and we have cloned full-length cDNA for three of these
genes. Zebrafish PGLYRP-2, PGLYRP-5, and PGLYRP-
6 each have one C-terminal PGRP domain that is con-
served through evolution, and these proteins are
predicted to be amidases.
Differential Expression of Zebrafish PGLYR-2,
PGLYR-5, and PGLYR-6
We performed both RNA and protein analysis to identify
tissues that express the different PGLYRP proteins. Total
RNA isolated from different tissues from adult zebrafish
was analyzed by RNA blots. Both PGLYRP-2 and
PGLYRP-5 mRNA were strongly expressed in the egg and
had lower expression in the liver (Figure 1). PGLYRP-5
mRNA was also expressed in the intestine and gill (Fig-
ure 1). In contrast, PGLYRP-6 was strongly expressed in
the intestine and weakly expressed in the liver (Figure 1).
In situ hybridization of whole fish sections with RNA
probes for the three PGLYRPs demonstrated a similarmunity 27, 518–529, September 2007 ª2007 Elsevier Inc. 519
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PGLYRP-5 transcripts were strongly expressed in the de-
veloping oocytes (stages II, III, and IV shown for PGLYRP-
2, Figure 2A; stage V shown for PGLYRP-5, Figure 2E).
PGLYRP-2 and PGLYRP-5 mRNAs were also expressed
in hepatocytes in the liver (Figures 2C and 2G). PGLYRP-6
was strongly expressed in the absorptive cells of the intes-
tine with no expression in the goblet cells (Figure 2I). The
staining was specific for all PGLYRPs as only the antisense
probes (Figures 2A, 2C, 2E, 2G, and 2I) and not the sense
probes (Figures 2B, 2D, 2F, 2H, and 2J) hybridized.
We next identified tissues that express PGLYRP pro-
teins in sections of whole adult fish by using antibodies
specific to each of the zebrafish proteins. PGLYRP-2,
PGLYRP-5, and PGLYRP-6 proteins were expressed in
hepatocytes and in the lumen of sinusoids in the liver (Fig-
ures 3A–3C). PGLYRP-2 and PGLYRP-5 proteins were
highly expressed in the exocrine acinar cells of the pan-
creas, whereas PGLYRP-6 had lower expression (Figures
3E–3G). In contrast, PGLYRP-6 was highly expressed in
the absorptive cells of the intestine, whereas PGLYRP-2
and PGLYRP-5 had lower expression (Figures 3I–3K).
There was no expression of either PGLYRP proteins in
the goblet cells. PGLYRP-2 was strongly expressed in
stages III to V of the developing oocyte (Figure 3M),
whereas PGLYRP-5 had somewhat lower expression
(Figure 3N) and PGLYRP-6 had the lowest expression
(Figure 3O). The three PGLYRPs were detected in the gills
and were present in a population of epithelial cells lining
the gill lamella and in the vascular lumen of the gills (Fig-
ures 3Q–3S). PGLYRP-2, PGLYRP-5, and PGLYRP-6
were expressed in the alarm cells but not in the mucous
cells and not in the taste buds of the integumentary
Figure 1. Zebrafish PGLYRP-2, PGLYRP-5, and PGLYRP-6
mRNAs Are Differentially Expressed in Various Tissues
RNA blots with RNA isolated from different adult zebrafish tissues were
hybridized with the indicated probes and exposed to X-ray film.
Hybridization with the 18S ribosomal probe demonstrates equal
loading of the RNA samples. The results are from one of three similar
experiments.520 Immunity 27, 518–529, September 2007 ª2007 Elsevier IncFigure 2. PGLYRP-2, PGLYRP-5, and PGLYRP-6 Transcripts
Are Differentially Expressed in Developing Oocytes, Liver,
and Intestine of Adult Zebrafish
Sections of zebrafish developing oocytes (A and B) and liver (C and D)
were hybridized with PGLYRP-2 antisense (A and C) or sense (B and D)
RNA probes. Sections of developing oocytes (E and F) and liver (G and
H) were hybridized with PGLYRP-5 antisense (E and G) or sense (F and
H) probes. Sections of intestine (I and J) were hybridized with
PGLYRP-6 antisense (I) or sense (J) probes. Scale bars represent
50 mm. The results are from one of three similar experiments..
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Zebrafish Peptidoglycan Recognition ProteinsFigure 3. Zebrafish PGLYRP-2, PGLYRP-5, and PGLYRP-6 Proteins Are Expressed in the Liver, Pancreas, Intestine, Developing
Oocytes, Gills, and Skin of Adult Zebrafish
Sections of zebrafish liver (A–D), pancreas (E–H), intestine (I–L), developing oocytes (M–P), gills (Q–T), and skin (U–X) were reacted with PGLYRP-2 (A,
E, I, M, Q, and U), PGLYRP-5 (B, F, J, N, R, and V), PGLYRP-6 (C, G, K, O, S, and W), or control (D, H, L, P, T, and X) antibody, stained with peroxidase,
and counterstained with hematoxylin. Scale bars for (A)–(L) represent 25 mm, and scale bars for (M)–(X) represent 50 mm. The results are from one of
three similar experiments.Immunity 27, 518–529, September 2007 ª2007 Elsevier Inc. 521
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PGLYRP-6 were also expressed in the epithelial cells of
the kidney tubules (data not shown). There was no staining
with the control antibody (Figures 3D, 3H, 3L, 3P, 3T, and
3X), indicating specific detection of PGLYRP proteins in
these tissues.
These data demonstrate that zebrafish PGLYRPs are
selectively expressed in a wide range of tissues including
those, such as gills, skin, and eggs, that are exposed to
bacteria in the surrounding water and are also expressed
in tissues, such as liver, that would be exposed to bacteria
during a systemic infection.
Amidase Activity of Zebrafish PGLYRP-2,
PGLYRP-5, and PGLYRP-6
On the basis of the presence of all four conserved amino
acids needed for the amidase activity of insect and mam-
malian PGLYRPs and bacteriophage type-2 amidases
(Figure S2), we hypothesized that zebrafish PGLYRPs
also have amidase activity for bacterial peptidoglycan.
To test this hypothesis, we determined whether purified
zebrafish PGLYRP proteins hydrolyze peptidoglycan.
We first used soluble polymeric Staphylococcus aureus
peptidoglycan labeled with biotin on the N-terminal gly-
cine in its peptide as a substrate. All three zebrafish
PGLYRPs hydrolyzedS. aureuspeptidoglycan (Figure 4A).
Amidase-active PGRPs and other type-2 amidases hydro-
lyze the lactyl-amide bond between the MurNAc and
L-Ala, which is the first amino acid in the stem peptide.
To determine which bond in peptidoglycan is hydrolyzed
by zebrafish PGLYRPs, we used synthetic peptidoglycan
fragments (MurNAc-pentapeptides) and identified the di-
gestion products by using mass spectrometry. Further-
more, on the basis of our sequence analysis, zebrafish
PGLYRP-2 and PGLYRP-6 were predicted to be DAP spe-
cific (Figure S2). We tested whether zebrafish PGLYRPs
hydrolyze both DAP- and Lys-containing muramyl pep-
tides (Figure 4B). We also used a muramyl-peptide with
N-acetylated Lys, MurNAc-L-Ala-D-isoGln-L-Lys(NHAc)-
D-Ala-D-Ala (which mimics Gly that is often bound to
the g-amino group of Lys in Gram-positive peptido-
glycans), to determine whether zebrafish PGLYRPs have
a preference for hydrolyzing such a substituted peptide.
The results demonstrated that all three zebrafish
PGLYRPs are N-acetylmuramoyl-L-alanine amidases
(Figure 4C). PGLYRP-6 hydrolyzed both Lys- (nonacety-
lated and N-acetylated) and DAP-containing muropepti-
des equally well. PGLYRP-2 hydrolyzed DAP-containing
and N-acetylated-Lys-containing muropeptides equally
well, but it was less effective on nonacetylated Lys-
containing muropeptide. PGLYRP-5 had lower activity
than PGLYRP-2 and PGLYRP-6 and showed preference
for DAP-containing muropeptide (Figure 4).
These data show that all three zebrafish PGRPs are type
2 amidases. The amidase activity is consistent with the
earlier discussed prediction of amidase activity of all three
zebrafish PGLYRPs on the basis of the presence of all four
conserved Zn2+-binding amino acids. Our results are con-
sistent with the idea that peptidoglycan-binding groove522 Immunity 27, 518–529, September 2007 ª2007 Elsevier Incspecific for DAP-containing peptide can also accommo-
date Lys-containing peptide, which is less bulky, i.e., con-
tains H found in Lys instead of COOH found in DAP (the
only difference between Lys and DAP).
Bactericidal Activity of Zebrafish PGLYRP-2,
PGLYRP-5, and PGLYRP-6
We have recently demonstrated that three human
PGLYRPs (PGLYRP-1, PGLYRP-3, and PGLYRP-4) are
bactericidal (Lu et al., 2006; Wang et al., 2007). Therefore,
here we tested the hypothesis that zebrafish PGLYRPs
may be also bactericidal. Moreover, because the antibac-
terial activity of amidase-active Drosophila PGRP-SB1 is
limited to B. megaterium (Mellroth and Steiner, 2006),
we tested whether zebrafish PGLYRPs have a broad or
a narrow spectrum bactericidal activity.
All three zebrafish PGLYRPs were strongly bactericidal
for Gram-positive bacteria: They reduced the numbers of
Bacillus subtilis, S. aureus, and Listeria monocytogenes
by 4–5 logs in 1, 2, or 4 hr, respectively (Figure 5A). These
PGLYRPs also had similar bactericidal effect on Gram-
negative bacteria, although the sensitivity of Gram-
negative bacteria to various proteins somewhat varied:
Salmonella enterica was highly sensitive to all three pro-
teins, whereasEscherichiacoli,Proteusvulgaris, andPseu-
domonas aeruginosa were less sensitive to PGLYRP-6,
and P. vulgaris and P. aeruginosa were also less sensitive
to PGLYRP-5 or PGLYRP-2, respectively (Figure 5A).
The LD99 (the concentration that kills 99% of bacteria) of
PGLYRP-2, PGLYRP-5, and PGLYRP-6 for B. subtilis
were 13 mg/ml (0.2 mM), 6 mg/ml (0.2 mM), and 1.3 mg/ml
(0.02 mM), respectively; and for S. enterica, the LD99
were 15 mg/ml (0.2 mM), 33 mg/ml (1.0 mM), and 33 mg/ml
(0.6 mM), respectively (Figure 5B). Thus, Gram-positive
B. subtilis is most sensitive to PGLYRP-6, and Gram-
negative S. enterica is most sensitive to PGLYRP-2.
Because the bactericidal activity of human PGLYRPs
required Zn2+, we then tested whether bactericidal activity
of zebrafish PGLYRPs also required Zn2+. All three zebra-
fish PGLYRPs, similar to human PGLYRPs, required 5 mM
Zn2+ for their bactericidal activity. They were not bacteri-
cidal when purified and assayed without Zn2+, and re-
moval of Zn2+ with EGTA, which has a high affinity for
Zn2+ (the log stability constant for Zn2+ is 12.9, compared
to 11.0 for Ca2+), abolished the bactericidal activities of all
three PGLYRPs (Figure 5C).
These results demonstrate that zebrafish PGLYRPs, in
addition to their amidase activity and unlike other ver-
tebrate amidases, are also bactericidal. Zebrafish
PGLYRPs, similar to human bactericidal PGLYRPs, have
broad-spectrum Zn2+-dependent bactericidal activity,
and at least one zebrafish PGLYRP (PGLYRP-6) has
greater bactericidal activity than human PGLYRPs.
PGLYRP-2 and PGLYRP-5 Are Expressed in the
Developing Embryos, and PGLYRP-5 Is Required
for In Vivo Protection against Infection
Lower vertebrates such as fish depend on innate immu-
nity, particularly during the early stages of development.
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Are Enzymes with N-Acetylmuramoyl-
L-Alanine Amidase Activity
(A) S. aureus soluble polymeric peptidoglycan,
labeled with biotin on terminal Gly, was incu-
bated in buffer alone or with the indicated
PGLYRPs for 24 or 96 hr. High-molecular-
weight polymeric biotin-peptidoglycan was
detected on an immunoblot with streptavidin-
peroxidase. Hydrolysis of the peptide from
the glycan chain removes the biotin-labeled
peptide. The results are from one of two similar
experiments.
(B and C) The muropeptides indicated in (B)
were incubated in buffer alone (control) or in
the presence of the indicated PGLYRPs, and
the hydrolysis products were identified with
MALDI-TOF MS; peaks for the indicated pep-
tides and observed masses ([M + Na]+) are
shown in (C). The vertical scale in the left-
hand PGLYRP-5 and PGLYRP-2 panels was
expanded so that minor peaks are revealed.
The unlabeled peaks are either matrix or buffer
adduct peaks that are the same in both di-
gested and undigested samples or reflect nat-
ural isotopic distribution of the digestion prod-
ucts. K+ adducts of the same peptides were
also detected (not shown). The hydrolyzed
bond is indicated in (B) by an arrow. Identical
hydrolysis products were generated by incu-
bation of the same substrates with human
PGLYRP-2, a proven N-acetyl-muramoyl-
L-alanine amidase (Wang et al., 2003), as a
positive control (not shown). The results are
from one of two similar experiments.because adaptive immunity matures later. In order to iden-
tify the role of PGLYRPs in the embryo during bacterial in-
fection, we first analyzed the expression of these proteins
in zebrafish embryos at different stages of development.
PGLYRP-2 protein is expressed in eggs and in embryos
(Figure 6A), whereas PGLYRP-5 protein is not expressed
in the eggs, is weakly expressed in the 24 hr postfertiliza-
tion (hpf) embryo, and is strongly expressed in the 72 hpf
embryo (Figure 6B). PGLYRP-6 protein could not be de-
tected in the eggs or in the early stages of development.IWe next determined the role of PGLYRP proteins in re-
sistance to bacterial infection in the developing embryo.
We initially selected PGLYRP-2 and PGLYRP-5 for these
experiments because both proteins are expressed in the
developing embryos (Figures 6A and 6B). Morpholinos
that bind mRNA and block translation were designed for
both PGLYRP-2 and PGLYRP-5. The morpholino de-
signed for blocking PGLYRP-5 specifically inhibited trans-
lation of this protein, and there was no inhibition with the
control morpholino (Figure 6C). PGLYRP-2 protein,mmunity 27, 518–529, September 2007 ª2007 Elsevier Inc. 523
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Zebrafish Peptidoglycan Recognition ProteinsFigure 5. Zebrafish PGLYRPProteins AreBactericidal for Several Gram-Positive andGram-Negative Bacteria andRequire Zn2+ for
Bactericidal Activity
Zebrafish PGKYRP proteins kill 99% ofB. subtilis at1.3–13 mg/ml (0.02–0.2 mM) andS. enterica at15-33 mg/ml (0.2–1.0 mM). The indicated bacteria
were incubated with different PGLYRPs or BSA as a control at (A and C) 100 mg/ml for the indicated time or (B) the indicated concentrations for 1 to
2 hr. In addition, PGLYRPs were treated or not treated with EGTA, as indicated (C). The numbers of bacteria were determined by colony counts. The
results are means of three (mostly) or two experiments; the average standard errors were 15% of the mean (ranged from 8%–24%) and are not shown
because the error bars were mostly smaller than the size of the symbols in the figures. The significance of differences was calculated with the
Student’s t test, and all differences in bacterial numbers greater than 1 log10 were statistically significant at p < 0.05.however, was already synthesized in large amounts in the
developing oocytes, and its concentration could not be
reduced by injection of morpholinos (data not shown).
Embryos, in which the expression of the endogenous
PGLYRP-5 protein was inhibited by an injection of a spe-
cific morpholino, were then tested for resistance to infec-
tions with the Gram-negative (S. enterica) and the Gram-
positive (B. subtilis) bacteria. Embryos injected with either
a control (C Mo) or the PGLYRP-5 (P5 Mo) morpholino
were subsequently challenged with S. enterica and as-
sayed for survival at 4 hr postinfection (hpi). Embryos in-
jected with control morpholino had 94% survival, whereas
embryos injected with PGLYRP-5 morpholino had 0%
survival (Figure 6D, p < 0.0001, control versus PGLYRP-
5 morpholino). To confirm that the increased mortality of524 Immunity 27, 518–529, September 2007 ª2007 Elsevier Incthe embryos was due to the developing infection (mani-
fested by increasing numbers of bacteria in the embryos),
we determined the numbers of S. enterica recovered from
live embryos, which were lysed at 2–3 hpi. Embryos
injected with PGLYRP-5 morpholino had significantly
(p < 0.0001) higher numbers of bacteria than the embryos
injected with a control morpholino (Figure 6E). The latter
embryos were able to eliminate virtually all injected
bacteria within 4 hr (Figure 6E).
Similar results were obtained in infection experiments
with B. subtilis. Embryos injected with a control morpho-
lino or with PGLYRP-5 morpholino followed by B. subtilis
infection had 100% and 10% survival, respectively (Fig-
ure 6F, p < 0.0001, control versus PGLYRP-5 morpholino).
To determine the numbers of B. subtilis recovered, we.
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Expressed in the Developing Embryos,
and PGLYRP-5 Is Essential for In Vivo
Protection against Infection
(A–C) Cell lysates from eggs or from embryos
at the indicated developmental stage were an-
alyzed by immunoblotting with PGLYRP-2 (A)
or PGLYRP-5 (B and C) antibody. Size markers
are shown on the left. The results are from one
of three similar experiments.
(D–K) Eggs at the two- to eight-cell stage were
injected with 1 nl of 0.5 mM PGLYRP-5 mor-
pholino (P5 Mo) or a control morpholino
(C Mo). At the onset of circulation (30 hpf),
embryos were injected with S. enterica (D
and E) or B. subtilis (F and G) or with S. enterica
(H and I) or B. subtilis (J and K) and PGLYRP-5
protein (P5 protein) or buffer. Embryos were
assayed for survival at 4 hpi or lysed for deter-
mining numbers of recovered bacteria per em-
bryo at 2–3 hpi. The data in each panel are from
two to three experiments with the following to-
tal numbers of embryos with C Mo and P5 Mo
or  and + P5 protein, respectively: (D), 18 and
24; (E), 35 and 43; (F), 24 and 19; (G), 24 and 21;
(H), 16 and 9; (I), 16 and 12; (J), 16 and 15; (K),
20 and 28. The survival and the numbers of re-
covered bacteria were significantly different at
p = 0.0002 (*) or p < 0.0001 (**) between
PGLYRP-5 morpholino- and control morpho-
lino-injected groups or between PGLYRP-5
protein-injected and buffer-injected groups.
The bactericidal results are means ± SE from
two to three experiments.lysed live embryos at 2–3 hpi. Embryos injected with
PGLYRP-5 morpholino had significantly (p < 0.0001)
higher numbers of bacteria than the embryos injected
with a control morpholino (Figure 6G). The latter embryos
were able to eliminate virtually all injected bacteria within
4 hr (Figure 6G).
To confirm the in vivo role of PGLYRP-5 in eliminating
bacteria and in the survival of the infected embryos, we
then performed rescue experiments. Embryos were first
injected with PGLYRP-5 morpholino so that the produc-
tion of endogenous PGLYRP-5 protein could be sup-
pressed. These embryos were then injected with purified
PGLYRP-5 protein or buffer alone at the time of S. enterica
orB. subtilis challenge. Injection of PGLYRP-5 protein, but
not buffer, significantly (p = 0.0002) increased the survival
of the embryos infected with S. enterica (Figure 6H) and
B. subtilis (Figure 6J). Similarly, injection of PGLYRP-5
protein, but not buffer, enabled the embryos to kill the
infecting bacteria (S. enterica, Figure 6E; and B. subtilis,
Figure 6K, p < 0.0001). Thus, these results confirm that
PGLYRP-5 protein is responsible for eliminating both Sal-Immonella andBacillus from the embryos and for the survival
of the embryos during bacterial infections.
DISCUSSION
Our results demonstrate the essential role of innate immu-
nity in defense against infections in fish and identify the
component of their innate immune system responsible
for this effect (bactericidal PGRPs). Because fish eggs
and developing embryos have to survive in bacteria-
containing water before adaptive immunity develops, dur-
ing that time they have to rely solely on innate immunity for
defense against infections and survival. Up until now,
this requirement was assumed, but to the best of our
knowledge, there was no experimental evidence for it.
Moreover, our results demonstrate an absolute require-
ment for a PGRP molecule in defense and survival against
bacterial infections in vertebrates.
Zebrafish PGLYRP-2, PGLYRP-5, and PGLYRP-6 pro-
teins (which we identified and cloned) are highly con-
served and have one PGRP domain, which is homologousmunity 27, 518–529, September 2007 ª2007 Elsevier Inc. 525
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PGRPs. Zebrafish PGLYRPs, similar to human PGLYRPs,
are selectively expressed in a wide range of tissues includ-
ing the liver, intestine, pancreas, maturing oocytes, gills,
and skin and are secreted in the lumen of the sinusoids
in the liver and in the blood vessels of the gills. All three
proteins are expressed in the developing oocytes, al-
though there may be quantitative differences in their
expression. PGLYRP-2 is also strongly expressed in the
eggs, and both PGLYRP-2 and PGLYRP-5 are expressed
in the developing embryo. This expression of PGLYRPs in
a wide range of tissues suggests an important role for this
family of proteins in defense of adult zebrafish against
bacterial infections. Furthermore, the expression profile
of PGLYRPs would allow the fish to combat bacteria
both in the surrounding water and internalized bacteria
during a systemic infection. Expression of PGLYRPs in
the eggs also equips the developing embryo with innate
immune mechanisms to fight bacterial infections before
the development of adaptive immunity.
We have demonstrated that PGLYRP-2, PGLYRP-5,
and PGLYRP-6 digest polymeric peptidoglycan. Further-
more, the three proteins specifically hydrolyze the lactyl-
amide bond between the MurNAc and L-Ala, and this
hydrolyzation confirms that PGLYRP-2, PGLYRP-5, and
PGLYRP-6 are N-acetylmuramoyl-L-alanine amidases,
similar to mammalian PGLYRP-2 and Drosophila PGRP-
SC1, PGRP-LB, and PGRP-SB1 (Wang et al., 2003; Gelius
et al., 2003; Kim et al., 2003; Mellroth et al., 2003; Sang
et al., 2005; Mellroth and Steiner, 2006).
In addition to the amidase activity, zebrafish PGLYRP-2,
PGLYRP-5, and PGLYRP-6 are also bactericidal. The
three proteins kill several different Gram-positive bacteria
equally efficiently but show somewhat differential killing of
several Gram-negative bacteria. Some of these bacteria
are human pathogens and are also pathogenic for
zebrafish, producing symptoms similar to those in humans
(van der Sar et al., 2003; van der Sar et al., 2004). How-
ever, zebrafish PGLYRPs are different from human bacte-
ricidal PGLYRP-1, PGLYRP-3, and PGLYRP-4 because
the human proteins have no amidase activity. Human
PGLYRP-2 is an amidase; however, it is not known
whether it is also bactericidal. One insect PGRP,Drosoph-
ila PGRP-SB1, has both amidase and antibacterial activi-
ties (Mellroth and Steiner, 2006). However, the spectrum
of antibacterial activity of PGRP-SB1 was very narrow
and limited to only B. megaterium, unlike the broad spec-
trum of antibacterial activity by human (Lu et al., 2006;
Wang et al., 2007) and zebrafish PGLYRPs (this study).
The bactericidal activity of PGLYRP-2, PGLYRP-5, and
PGLYRP-6 requires zinc, similar to human PGLYRPs (Lu
et al., 2006; Wang et al., 2007).
The killing mechanism by human bactericidal PGRPs
most probably targets the bacterial cell wall and does
not involve peptidoglycan hydrolysis or permeabilization
of the cytoplasmic membrane (Lu et al., 2006; Wang
et al., 2007). Zebrafish PGRPs, unlike human PGRPs,
have both amidase and bactericidal activities. Thus, their
mechanism of action may be different.526 Immunity 27, 518–529, September 2007 ª2007 Elsevier IncWe have further demonstrated that PGLYRP-5 is re-
quired in the zebrafish embryo for eliminating bacteria
and for survival of the embryo during bacterial infections.
We selected S. enterica and B. subtilis for these experi-
ments because both bacteria are highly sensitive to the
bactericidal activity of zebrafish PGLYRPs, are free-living
and found in water and thus infect aquatic life such as fish
and turtles, are not highly pathogenic for zebrafish, and
are rapidly eliminated in the normal developing embryo.
The ability of the host to eliminate bacteria with innate im-
mune mechanisms may be an important property that dif-
ferentiates less pathogenic from more pathogenic bacte-
ria. PGLYRP-5 is expressed in the developing embryo at
an estimated concentration of 100 mg/ml at 24 hpf. This
concentration of PGLYRP-5 protein is based on an esti-
mated total volume of 0.3 ml/embryo (24 hpf) and the
amount of endogenous PGLYRP-5 protein detected on
the western blot (30 ng per 24 hpf embryo). This con-
centration of PGLYRP-5 is more than sufficient to kill
1 to 5 3 107 bacteria/ml (100–500 bacteria/embryo)—
the numbers of bacteria that were injected into the em-
bryo. This calculation is based on our in vitro bactericidal
assays, in which LD99 of PGLYRP-5 is 6 mg/ml for B. sub-
tilis and 33 mg/ml forS. enterica at 1 to 53 106 bacteria/ml,
and was verified in our rescue experiments with recom-
binant PGLYRP-5 injected into PGLYRP-5-depleted
embryos (Figure 6H-K).
To our knowledge, this is the first demonstration of an
essential role for a PGLYRP protein in the survival of ver-
tebrates and contrasts with the results of two previous
studies: One study showed partial requirement for
PGLYRP-1 in resistance to infection in mice (Dziarski
et al., 2003), and the second study concluded that
PGLYRP-2 was not essential for immunity in mice (Xu
et al., 2004). Our results also demonstrate the importance
of innate immunity molecules in the defense against bac-
terial pathogens, especially during the early stages of
development when there is no adaptive immunity.
In conclusion, we have cloned a family of PGLYRP pro-
teins from an earlier vertebrate, the zebrafish, and we have
identified the function of PGLYRP-2, PGLYRP-5, and
PGLYRP-6 proteins. Zebrafish PGLYRP proteins are ex-
pressed in several tissues in adult zebrafish and are differ-
entially expressed in the developing embryos. These pro-
teins are unique compared to other vertebrate PGLYRPs
because they have both amidase activity and a broad-
spectrum bactericidal activity. Furthermore, zebrafish
PGLYRP-5 is essential for defense against bacterial infec-
tions in the developing embryos. Thus, our results demon-
strate that in zebrafish, innate immunity (and PGLYRP pro-
teins in particular) is essential for defense against
infections and survival of developing embryos.
EXPERIMENTAL PROCEDURES
Maintenance of Zebrafish
Adult zebrafish, Danio rerio, were obtained from the Zebrafish Interna-
tional Resource Center (supported by grant #RR12546 from NIH-
NCRR), University of Oregon. Zebrafish were housed and maintained.
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‘‘The Zebrafish Book,’’ University of Oregon (www.zfin.org). All exper-
iments with fish were approved by the Institutional Animal Care and
Use Committee at Indiana University School of Medicine Northwest.
Cloning of Zebrafish pglyrp Genes
We identified four zebrafish PGLYRP genes in the GenBank databases
and have cloned cDNAs for three PGLYRPs. All cloning was done by
RACE reactions and by RT-PCR with total RNA isolated from adult ze-
brafish tissues. The cDNAs for the three PGLYRPs were initially cloned
with RACE nested primers (see Table S1) on the basis of the following
EST clones: CF999082 and CK029852 (PGLYRP-2); CO92224
(PGLYRP-5); and AL922460 (PGLYRP-6). RACE reactions were done
with the First-Choice RLM-RACE kit (Ambion). The 50 RACE products
for the three PGLYRPs were extended at the 50 end with primers on the
basis of the GenBank predicted protein sequences XM691972
(PGLYRP-2), XM697301 (PGLYRP-5), and XM695448 (PGLYRP-6)
for producing full-length cDNAs. The 30 RACE reactions resulted in
clones with poly(A) tails. All clones were analyzed by restriction diges-
tion and sequencing. Final sequences were analyzed for signal pep-
tides with the SPScan program (Genetic Computer Group) and for
transmembrane domains with the Swiss TMpred program. Multiple se-
quence alignments were performed with the ClustalW program with
MacVector (Genetic Computer Group).
In Vitro Transcription and Digoxigenin-Labeled RNA Probes
Zebrafish PGLYRP cDNAs were amplified with primers (Table S1) and
subcloned into the pGEM-T vector (Promega). This vector has dual-
opposed promoters that allow in vitro transcription of both strands of
the cloned DNA. For generating RNA probes, the clones were digested
with NcoI or NdeI, and the fragments were purified on an agarose gel
and used for separate in vitro transcription reactions with the Digoxy-
genin RNA Labeling Kit (Roche). Transcription was performed with SP6
RNA polymerase and T7 RNA polymerase so that antisense and sense
RNA probes could be generated.
Expression and Purification of PGLRP Proteins
The coding regions for zebrafish PGLYRPs were amplified (Table S1)
and subcloned into the expression vector pMT/BiP/V5-His vector (In-
vitrogen). Stable S2 cell lines were generated, expression of PGLYRPs
was induced with 500 mM CuSO4, and proteins were purified as de-
scribed before (Lu et al., 2006). All purification buffers included
40 mM ZnSO4; elution buffer also included 10% glycerol; and dialysis
buffer included 10 mM ZnSO4 and 10% glycerol (Wang et al., 2007).
The purity of the proteins was detected on Coomassie-blue-stained
blots (Figure S3). For removal of divalent cations, proteins were treated
with 100 mM EGTA for 10 min at room temperature and then used for
bactericidal assays. To test whether zebrafish PGLYRPs are glyco-
sylated, we treated proteins with the N-glycosidase, PNGase, and
analyzed them by western blots as described (Lu et al., 2006).
RNA and Northern Blots
Total RNA from eggs and 24 hr hpf, 48 hpf, and 72 hpf embryos or adult
zebrafish skin, muscle, liver, eggs, gills, intestine, brain, liver, and eyes
was purified with Trizol reagent (Invitrogen). A total of 30 mg of RNA
from each sample was analyzed by Northern blots. PGLYRP cDNA
clones were amplified with primers (Table S1) and used as a probe.
The 18S ribosomal clone, IMAGE ID 5604426, was used as a control.
DNA was labeled with 32P with RadPrime DNA Labeling System (Invi-
trogen), and hybridizations were done in ExpressHyb solution at 68C
(Wang et al., 2005). All probes were highly specific because they did
not crosshybridize with other members of the PGLYRP family (data
not shown).
In Situ Hybridization
Adult zebrafish were fixed in Bouin’s Reagent for 3 hr, rinsed in 70%
ethanol, embedded in paraffin, and 5-mm-thick, longitudinal sections,
were prepared by Transgenic Pathology Laboratory (University of Cal-Imifornia, Davis). The sections were incubated in prehybridization buffer
for 4 hr at 60C and an overnight incubation at 55C in hybridization
buffer containing 10 ng of digoxigenin labeled RNA probe. The sec-
tions were washed at 55C in the following series of wash solutions:
23 SSC, 23 SSC with 50% formamide, 23 SSC with 25% formamide,
13 SSC, and 0.13 SSC and then blocked with 2% normal sheep
serum. The sections were incubated with sheep anti-DIG-alkaline
phosphatase antibody overnight, and this was followed by color devel-
opment with nitroblue tetrazolium and 5-bromo-chloro-3-indolyl phos-
phate. The sections were counterstained with fast red.
Antibodies and Western Blots
PGLYRP antibodies to the following peptides: CETETHPKIKERLN
for PGLYRP-2, CSVLPKLRDRLQNNE for PGLYRP-5, and
CVRRNLNQDERKKLD for PGLYRP-6 were made and affinity purified
(Lu et al., 2006). These antibodies were specific for each PGLYRP,
as demonstrated by their reactivity on western blots with only one
PGLYRP from which the peptide was derived, and no reactivity with
the other PGLYRPs (Figure S3). An antibody to an unrelated peptide,
which did not react with zebrafish PGLYRPs, prepared and purified
by the same method, was used as a negative control. V5 mouse
monoclonal antibody was obtained from Invitrogen.
Total cell protein was prepared from eggs and embryos in SDS
sample buffer (The Zebrafish Book, www.zfin.org). Lysates from 20
eggs or embryos were analyzed by SDS-gels and western blots, with
antibodies specific for zebrafish PGLYRPs.
Immunohistochemistry
Adult zebrafish were fixed in Bouin’s Reagent and sectioned as de-
scribed above for in situ hybridization. After standard deparaffiniza-
tion, rehydration, and quenching of endogenous peroxidase by
30 min incubation in 0.3% H2O2, the slides were incubated with
1 mg/ml of anti-PGLYRP-2, anti-PGLYRP-5, anti-PGLYRP-6 or control
antibody (obtained and tested for specificity as described above) over-
night; this was followed by biotinylated second antibody and Vectas-
tain Elite ABC kit (Vector) with 3,30 diaminobenzidene as a substrate
(this generates a brown reaction product) and counterstaining with
hematoxylin (blue).
Peptidoglycan Digestion and Amidase Assays
Soluble uncrosslinked peptidoglycan, purified by vancomycin-affinity
chromatography from S. aureus Rb, was labeled with biotin on the
N-terminal glycine of its interpeptide bridge, and its hydrolysis was
measured as described previously (Wang et al., 2003). Peptidogly-
can-biotin (500 ng) was incubated for 24 or 96 hr at 37C with
500 ng of recombinant PGLYRP-2, PGLYRP-5, PGLYRP-6, or buffer
alone. Enzyme-digested peptidoglycan-biotin was subjected to
SDS-PAGE and blotted on Immobilon-P, and high Mr peptidoglycan-
biotin was detected with streptavidin-peroxidase and enhanced
chemiluminescence as described previously (Wang et al., 2003).
For determining which bond in peptidoglycan is hydrolyzed by ze-
brafish PGLYRPs, 10 mg of synthetic peptidoglycan fragments (Kumar
et al., 2005) were incubated for 72 hr in 4 mM TRIS (pH 7.6), with 60 mM
NaCl, 4 mM ZnSO4, and 4% glycerol, with 2 mg zebrafish PGLYRPs, or
human PGLYRP-2 as a positive control, or in buffer alone as a negative
control. The samples were analyzed by MALDI-TOF mass spectrome-
try, and digestion products were identified as described previously
(Wang et al., 2003).
Antimicrobial Assay
Bactericidal activity of zebrafish PGLYRP proteins was assayed as de-
scribed (Lu et al., 2006; Wang et al., 2007). In brief, PGLYRP proteins
purified from S2 cell supernatants, or BSA as a control, were incubated
with bacteria in a buffer containing 5 mM TRIS, pH 7.6, 150 mM NaCl,
5 mM ZnSO4, 5% glycerol, and 1% LB (50% Schaeffer’s medium was
used for B. subtilis instead of LB). The following bacteria were assayed
for sensitivity: B. subtilis, L. monocytogenes, S. aureus (clinical isolate
Rb), E. coliK12,P. vulgaris,P. aeruginosa, andS. enterica. The numbermunity 27, 518–529, September 2007 ª2007 Elsevier Inc. 527
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were performed as described previously (Lu et al., 2006). Bactericidal
activity is defined as an at least 2 log10 decrease in the number of
inoculated bacteria in 6 hr; bacteriostatic activity is defined as an
inhibition of growth of bacteria or a decrease in the number of inocu-
lated bacteria of less than 2 log10 in 6 hr. The significance of
differences was calculated with the Student’s t test, and all differences
in bacterial numbers greater than 1 log10 were statistically significant
at p < 0.05.
Infection of Zebrafish Embryos
Zebrafish eggs were rinsed with 0.003% sodium hypochlorite, sus-
pended in embryo medium, and transferred into an agarose injection
plate (Grabher et al., 2004). PGLYRP-5 (AAGATGAAGAAACTGTGCT
GCATGG) and control (CCTCTTACCTCAGTTACAATTTATA) morpho-
linos (Gene Tools) were at 0.5 mM concentration. We used a PV830
Pneumatic PicoPump (World Precision Instrument) to pressure inject
1 nl of morpholino solution into the yolk of two- to eight-cell-stage de-
veloping embryos. The embryos were placed at 28C in embryo me-
dium and observed under the microscope so that normal development
could be ensured. In initial experiments, embryos were observed for
60 hpf (this is26 hr longer than the infection experiments), and there
were no obvious morphological differences between the PGLYRP-5
and control morpholino-injected embryos. At 28–32 hpf, the embryo
heart was beating and the circulation had commenced. Embryos sim-
ilar in development were selected from PGLYRP-5, and control mor-
pholino-injected groups and the embryo yolk was injected with 1 nl
of an exponentially growing S. enterica or B. subtilis culture, diluted
so that 100–500 bacteria per injection could be produced. In initial ex-
periments, the entry of the bacteria into the circulation was monitored
with phenol red mixed with bacteria. The injected embryos were ob-
served under the microscope, and the sample was seen rapidly enter-
ing the circulation. We verified the dose of bacteria injected into each
embryo by dispensing an identical volume onto LB plates just before
and after each injection group. Subsequent culture of these plates
showed the same numbers of bacteria injected into each embryo treat-
ment group. After bacterial injections, the embryos were scored for
survival after 4 hr or were individually lysed and plated on LB agar
for determining the numbers of recovered bacteria at 2–3 hr. Longer
time points were not used because all PGLYRP-5 morpholino-
injected embryos challenged with bacteria were dead. For rescue ex-
periments, PGLYRP-5 purified protein (0.4 ng/embryo) was injected
into embryos with S. enterica or B. subtilis, and individual embryos
were assayed as described above. We used two types of control
injections: (1) control morpholinos, which had no effect on PGRP
expression, embryo development, and the course of infection and (2)
vehicle or buffer injections, instead of morpholinos, bacteria, or
PGRP protein, which had no harmful effects on the embryos (buffer-
injected embryos developed normally or had normal course of infec-
tions if subsequently challenged with bacteria). The survival results
were analyzed for significance of differences by the chi-square
test, the numbers of recovered bacteria are presented as geometric
means, and the significance of differences was determined by the
Mann-Whitney U test.
Supplemental Data
Additional Results and three figures are available at http://www.
immunity.com/cgi/content/full/27/3/518/DC1/.
ACKNOWLEDGMENTS
We are grateful to Patrick Bankston and William Hamlett for help in
interpreting the immunohistochemistry slides and David Lains, Chris-
ten Mumaw, and Nancy Mangini for advice on maintenance of zebra-
fish. This work was supported by USPHS Grants AI28797 and AI56395
from the National Institutes of Health to R.D. and D.G. and GM065248
to G.-J.B.528 Immunity 27, 518–529, September 2007 ª2007 Elsevier InReceived: March 16, 2007
Revised: June 4, 2007
Accepted: July 23, 2007
Published online: September 13, 2007
REFERENCES
Bischoff, V., Vignal, C., Boneca, I.G., Michel, T., Hoffmann, J.A., and
Royet, J. (2004). Function of the Drosophila pattern-recognition recep-
tor PGRP-SD in the detection of Gram-positive bacteria. Nat. Immunol.
5, 1175–1180.
Bischoff, V., Vignal, C., Duvic, B., Boneca, I.G., Hoffmann, J.A., and
Royet, J. (2006). Down regulation of the Drosophila immune response
by peptidoglycan-recognition proteins SC1 and SC2. PLoS Pathog. 2,
e14.
Choe, K.-M., Werner, T., Stoven, S., Hultmark, D., and Anderson, K.V.
(2002). Requirement for a peptidoglycan recognition protein (PGRP) in
Relish activation and antibacterial immune responses in Drosophila.
Science 296, 359–362.
DeVries, M.E., Kelvin, A.A., Xu, L., Ran, L., Robinson, J., and Kelvin,
D.J. (2006). Defining the origins and evolution of the chemokine/che-
mokine receptor system. J. Immunol. 176, 401–415.
Dziarski, R., and Gupta, D. (2006a). Mammalian PGRPs: Novel anti-
bacterial proteins. Cell. Microbiol. 8, 1059–1069.
Dziarski, R., and Gupta, D. (2006b). The peptidoglycan recognition
proteins (PGRPs). Genome Biol. 7, 232.
Dziarski, R., Platt, K.A., Gelius, E., Steiner, H., and Gupta, D. (2003).
Defect in neutrophil killing and increased susceptibility to infection
with nonpathogenic gram-positive bacteria in peptidoglycan recogni-
tion protein-S (PGRP-S)-deficient mice. Blood 102, 689–697.
Garver, L.S., Wu, J., and Wu, L.P. (2006). The peptidoglycan recogni-
tion protein PGRP-SC1a is essential for Toll signaling and phagocyto-
sis of Staphylococcus aureus in Drosophila. Proc. Natl. Acad. Sci. USA
103, 660–665.
Gelius, E., Persson, C., Karlsson, J., and Steiner, H. (2003). A mamma-
lian peptidoglycan recognition protein with N-acetylmuramoyl-
L-alanine amidase activity. Biochem. Biophys. Res. Commun. 306,
988–994.
Gottar, M., Gobert, V., Michel, T., Belvin, M., Duyk, G., Hoffmann, J.A.,
Ferrandon, D., and Royet, J. (2002). The Drosophila immune response
against Gram-negative bacteria is mediated by a peptidoglycan rec-
ognition protein. Nature 416, 640–644.
Grabher, C., Joly, J.-S., and Wittbrodt, J. (2004). Highly efficient zebra-
fish transgenesis mediated by the meganuclease I-SceI. Methods Cell
Biol. 77, 381–401.
Kaneko, T., and Silverman, N. (2005). Bacterial recognition and signal-
ling by the Drosophila IMD pathway. Cell. Microbiol. 7, 461–469.
Kang, D., Liu, G., Lundstrom, A., Gelius, E., and Steiner, H. (1998). A
peptidoglycan recognition protein in innate immunity conserved from
insects to humans. Proc. Natl. Acad. Sci. USA 95, 10078–10082.
Kim, M.-S., Byun, M., and Oh, B.-H. (2003). Crystal structure of pepti-
doglycan recognition protein LB from Drosophila melanogaster. Nat.
Immunol. 4, 787–793.
Kumar, S., Roychowdhury, A., Ember, B., Wang, Q., Guan, R.,
Mariuzza, R.A., and Boons, G.J. (2005). Selective recognition of syn-
thetic lysine and meso diaminopimelic acid-type peptidoglycan frag-
ments by human peptidoglycan recognition protein-Ialpha and -S. J.
Biol. Chem. 280, 37005–37012.
Lam, S.H., Chua, H.L., Gong, Z., Lam, T.J., and Sin, Y.M. (2004). De-
velopment and maturation of the immune system in zebrafish, Danio
rerio: A gene expression profiling, in situ hybridization and immunolo-
gical study. Dev. Comp. Immunol. 28, 9–28.
Lemaitre, B., Kromer-Metzger, E., Michaut, L., Nicolas, E., Meister, M.,
Georgel, P., Reichhart, J.M., and Hoffmann, J.A. (1995). A recessive
mutation, immune deficiency (imd), defines two distinct controlc.
Immunity
Zebrafish Peptidoglycan Recognition Proteinspathways in the Drosophila host defense. Proc. Natl. Acad. Sci. USA
92, 9465–9469.
Lemaitre, B., Nicolas,E., Michaut, L., Reichhart, J.M., and Hoffmann,J.A.
(1996). The dorsoventral regulatory gene cassette spatzle/Toll/cactus
controls the potent antifungal response in Drosophila adults. Cell 86,
973–983.
Leulier, F., Parquet, C., Pili-Floury, S., Ryu, J.-H., Caroff, M., Lee,
W.-J., Mengin-Lecreulx, D., and Lemaitre, B. (2003). The Drosophila
immune system detects bacteria through specific peptidoglycan rec-
ognition. Nat. Immunol. 4, 478–484.
Li, X., Wang, S., Wang, H., and Gupta, D. (2006). Differential expres-
sion of peptidoglycan recognition protein 2 in the skin and liver requires
different transcription factors. J. Biol. Chem. 281, 20738–20748.
Liu, C., Xu, Z., Gupta, D., and Dziarski, R. (2001). Peptidoglycan recog-
nition proteins: A novel family of four human innate immunity pattern
recognition molecules. J. Biol. Chem. 276, 34686–34694.
Lu, X., Wang, M., Qi, J., Wang, H., Li, X., Gupta, D., and Dziarski, R.
(2006). Peptidoglycan recognition proteins are a new class of human
bactericidal proteins. J. Biol. Chem. 281, 5895–5907.
Mellroth, P., Karlsson, J., and Steiner, H. (2003). A scavenger function
for a Drosophila peptidoglycan recognition protein. J. Biol. Chem. 278,
7059–7064.
Mellroth, P., and Steiner, H. (2006). PGRP-SB1: An N-acetylmuramoyl-
L-alanine amidase with antibacterial activity. Biochem. Biophys. Res.
Commun. 350, 994–999.
Michel, T., Reichhart, J.M., Hoffmann, J.A., and Royet, J. (2001). Dro-
sophila Toll is activated by Gram-positive bacteria through a circulating
peptidoglycan recognition protein. Nature 414, 756–759.
Park, J.W., Je, B.-R., Piao, S., Inamura, S., Fujimoto, Y., Fukase, K.,
Kusumoto, S., Soderhall, K., Ha, N.-C., and Lee, B.L. (2006). A syn-
thetic peptidoglycan fragment as a competitive inhibitor of the melani-
zation cascade. J. Biol. Chem. 281, 7747–7755.
Ramet, M., Manfruelli, P., Pearson, A., Mathey-Prevot, B., and Ezeko-
witz, R.A.B. (2002). Functional genomic analysis of phagocytosis and
identification of a Drosophila receptor for E. coli. Nature 416, 644–648.
Sang, Y., Ramanathan, B., Ross, C.R., and Blecha, F. (2005). Gene si-
lencing and overexpression of porcine peptidoglycan recognition pro-
tein long isoforms: Involvement in beta-defensin-1 expression. Infect.
Immun. 73, 7133–7141.
Trede, N.S., Langenau, D.M., Traver, D., Look, A.T., and Zon, L.I.
(2004). The use of zebrafish to understand immunity. Immunity 20,
367–379.
Trede, N.S., Zapata, A., and Zon, L.I. (2001). Fishing for lymphoid
genes. Trends Immunol. 22, 302–307.
Tydell, C.C., Yount, N., Tran, D., Yuan, J., and Selsted, M.E. (2002).
Isolation, characterization, and antimicrobial properties of bovine oli-Imgosaccharide-binding protein. A microbicidal granule protein of eosin-
ophils and neutrophils. J. Biol. Chem. 277, 19658–19664.
van der Sar, A.M., Appelmelk, B.J., Vandenbroucke-Grauls, C.M.J.E.,
and Bitter, W. (2004). A star with stripes: Zebrafish as an infection
model. Trends Microbiol. 12, 451–457.
van der Sar, A.M., Musters, R.J.P., van Eeden, F.J.M., Appelmelk, B.J.,
Vandenbroucke-Grauls, C.M.J.E., and Bitter, W. (2003). Zebrafish em-
bryos as a model host for the real time analysis of Salmonella typhimu-
rium infections. Cell. Microbiol. 5, 601–611.
Wang, H., Gupta, D., Li, X., and Dziarski, R. (2005). Peptidoglycan rec-
ognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in ker-
atinocytes by bacteria through the p38 kinase pathway. Infect. Immun.
73, 7216–7225.
Wang, M., Liu, L.-H., Wang, S., Li, X., Lu, X., Gupta, D., and Dziarski, R.
(2007). Human peptidoglycan recognition proteins require zinc to kill
both Gram-positive and Gram-negative bacteria and are synergistic
with antibacterial peptides. J. Immunol. 178, 3116–3125.
Wang, Z.-M., Li, X., Cocklin, R.R., Wang, M., Wang, M., Fukase, K., In-
amura, S., Kusumoto, S., Gupta, D., and Dziarski, R. (2003). Human
peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine
amidase. J. Biol. Chem. 278, 49044–49052.
Werner, T., Liu, G., Kang, D., Ekengren, S., Steiner, H., and Hultmark,
D. (2000). A family of peptidoglycan recognition proteins in the fruit fly
Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 97, 13772–
13777.
Xu, M., Wang, Z., and Locksley, R.M. (2004). Innate immune responses
in peptidoglycan recognition protein L-deficient mice. Mol. Cell. Biol.
24, 7949–7957.
Yoder, J.A., Nielsen, M.E., Amemiya, C.T., and Litman, G.W. (2002).
Zebrafish as an immunological model system. Microbes Infect. 4,
1469–1478.
Yoshida, H., Kinoshita, K., and Ashida, M. (1996). Purification of a pep-
tidoglycan recognition protein from hemolymph of the silkworm,
Bombyx mori. J. Biol. Chem. 271, 13854–13860.
Zhang, Y., van der Fits, L., Voerman, J.S., Melief, M.-J., Laman, J.D.,
Wang, M., Wang, H., Wang, M., Li, X., Walls, C.D., et al. (2005). Iden-
tification of serum N-acetylmuramoyl-L-alanine amidase as liver pep-
tidoglycan recognition protein 2. Biochim. Biophys. Acta 1752, 34–46.
Zaidman-Remy, A., Herve, M., Poidevin, M., Pili-Floury, S., Kim, M.S.,
Blanot, D., Oh, B.H., Ueda, R., Mengin-Lecreulx, D., and Lemaitre, B.
(2006). The Drosophila amidase PGRP-LB modulates the immune re-
sponse to bacterial infection. Immunity 24, 463–473.
Accession Numbers
The nucleotide sequences for PGLYRP-1, PGLYRP-5, and PGLYRP-6
have been submitted to GenBank, and their accession numbers are
DQ447202, DQ447203, and DQ447204, respectively.munity 27, 518–529, September 2007 ª2007 Elsevier Inc. 529
